These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 25643268)
1. Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond. Holmes NE; Tong SY; Davis JS; van Hal SJ Semin Respir Crit Care Med; 2015 Feb; 36(1):17-30. PubMed ID: 25643268 [TBL] [Abstract][Full Text] [Related]
2. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Culos KA; Cannon JP; Grim SA Am J Ther; 2013; 20(2):200-12. PubMed ID: 21642833 [TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options. Purrello SM; Garau J; Giamarellos E; Mazzei T; Pea F; Soriano A; Stefani S J Glob Antimicrob Resist; 2016 Dec; 7():178-186. PubMed ID: 27889013 [TBL] [Abstract][Full Text] [Related]
4. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Micek ST Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745 [TBL] [Abstract][Full Text] [Related]
5. Treatment of infections due to resistant Staphylococcus aureus. Anstead GM; Cadena J; Javeri H Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care. Tverdek FP; Crank CW; Segreti J Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. Maclayton DO; Hall RG Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections. Pea F; Petrosillo N; Garau J Expert Rev Anti Infect Ther; 2015 Aug; 13(8):927-37. PubMed ID: 26065544 [TBL] [Abstract][Full Text] [Related]
10. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci. Napolitano LM Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494 [TBL] [Abstract][Full Text] [Related]
11. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935 [TBL] [Abstract][Full Text] [Related]
12. Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections. Davis JS; Van Hal S; Tong SY Semin Respir Crit Care Med; 2015 Feb; 36(1):3-16. PubMed ID: 25643267 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC. Kao TM; Wang JT; Weng CM; Chen YC; Chang SC J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980 [TBL] [Abstract][Full Text] [Related]
14. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus. Salem AH; Zhanel GG; Ibrahim SA; Noreddin AM Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387 [TBL] [Abstract][Full Text] [Related]
15. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment]. Pangercić A; Bukovski-Simonoski S; Barsić B Lijec Vjesn; 2010; 132 Suppl 1():11-3. PubMed ID: 20715711 [TBL] [Abstract][Full Text] [Related]
16. Treatment of infections caused by resistant Staphylococcus aureus. Anstead GM; Quinones-Nazario G; Lewis JS Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681 [TBL] [Abstract][Full Text] [Related]
17. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types. Farrell DJ; Flamm RK; Sader HS; Jones RN Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474 [TBL] [Abstract][Full Text] [Related]
18. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS; Trials; 2016 Mar; 17():170. PubMed ID: 27029920 [TBL] [Abstract][Full Text] [Related]
19. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin. Mohan SS; McDermott BP; Cunha BA Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]